陈建同查看源代码讨论查看历史
陈建同（Chen Jiann-Thorng）（1962年－）是中华民国陆军中将，生于台湾省花莲县花莲市，现任国防部军医局中将局长，曾任国防部军医局少将副局长、国防医学院上校教学副院长、医学系主任、陆军后勤指挥部军医处少将处长，毕业于花岗国中、花莲高中、国防医学院医学 系、获得美国纽约州立大学哲学博士。三军总医院眼科部主治医师。 中华民国眼科医学会理事长 。学术专长：分子生物学，细胞学，病理学，眼科。
1998年，陈建同以论文: The Nature of the resistance to steroid hypertension in Wistar-Furth rats. 获得纽约州立大学水牛城分校博士学位；指导教授是Dr.Samuel Gallant博士。
生平
医疗纠纷
因医疗纠纷，堕胎并发眼疾致失明，经法院判决，认定诊治医师陈建同在病情发生变化时，未重新检查追查原因，延误治疗，改判三总及陈建同医师判赔244 万。经查证后，陈建同先生博士论文为内科高血压之研究，非眼科，专业判断受到质疑而导致医疗疏失。
博士论文争议
陈建同博士所发表的论文，与Dr. Yu, Cheng-Ping之相似度高达百分之60，有学术剽窃plagiarism之可能性。由于近年来国军高阶将官论文抄袭事件层出不穷，前国防部长杨念祖闪辞，震惊全国，也启动教育部对于高阶将官博士论文之审查。 陈建同博士论文。 但反方辩护，陈建同博士1998年发表的博士论文，只有在结构和实验设计上与Dr. Yu 于1997年所发表的博士论文，有部分雷同之处，并无学术剽窃的事实。因为在撰写论文时，结构体上过于相似，造成误解。双方论点，仍然需协力厂商学术单位公证。因此，有关论文争议事件，完全属于假设，并非事实。
陈建同博士于1998年，发表的博士论文，题目如下:
- "The Nature of the Resistance to Steroid Hypertension in Wistar Furth Rats"
于1997年，Dr. Yu 所发表的博士论文，题目如下:
- "The Nature of the Resistance to Steroid Hypertension in Wistar Furth Rats"
- "Studies of Steroid-induced Hypertension in Wistar and Wistar/Furth Rats"
- 经过文本分析，内容相似度颇高，且实验方法与设计，几乎相同；英文的用字也非常雷同；由于发表的年分接近，学术剽窃的疑虑仍然存在，目前尚待查正并厘清。
论文摘要分析
协力厂商，对于两位学者的论文摘要进行比对分析，结果如下。
Dr. Yu, 1997, Studies of Steroid-induced Hypertension in Wistar and Wistar/Furth Rats 论文摘要:
陈建同博士，1998年，The Nature of the Resistance to Steroid Hypertension in Wistar Furth Rats论文摘要:
“
Abstract
The Nature of the resistance of the Wistar-Furth(W/fu) rat strain to steroid hypertension was investigated.The basal levels of renal kallikrein mRNA and kallikrein activity measured in intact or uninephrectomized animals were higher in W/Fu than in WI rats. The induction of renal kallikrein mRNA in response to DOCA treatment was similar in both strains. However Renal kallikrein activity increased progressively in W/Fu rats and declined in WI rats. Both urinary total and active kallikrein activities were higher in DOCA-treated W/Fu rats than in the similar treated WI rats.
Co-adminstration of DOCA and Hoe 140, a bradykinin type 2 receptor antagonist, raised the blood pressure of W/Fu rats into the hypertension range. Furthermore, with this regimen W/Fu rats developed hypernatremia. These findings suggest that bradykinin(a product of kallikrein action) plays an important role in the resistance of W/Fu rats to mineralocorticoid hypertension. Collectively, these results suggest that W/Fu rats have a more active renal kallikrein-kinin system.
”
The Nature of the resistance of the Wistar-Furth(W/fu) rat strain to steroid hypertension was investigated.The basal levels of renal kallikrein mRNA and kallikrein activity measured in intact or uninephrectomized animals were higher in W/Fu than in WI rats. The induction of renal kallikrein mRNA in response to DOCA treatment was similar in both strains. However Renal kallikrein activity increased progressively in W/Fu rats and declined in WI rats. Both urinary total and active kallikrein activities were higher in DOCA-treated W/Fu rats than in the similar treated WI rats.
Co-adminstration of DOCA and Hoe 140, a bradykinin type 2 receptor antagonist, raised the blood pressure of W/Fu rats into the hypertension range. Furthermore, with this regimen W/Fu rats developed hypernatremia. These findings suggest that bradykinin(a product of kallikrein action) plays an important role in the resistance of W/Fu rats to mineralocorticoid hypertension. Collectively, these results suggest that W/Fu rats have a more active renal kallikrein-kinin system.
辩护方认为，虽然实验设计方法类似，但实验结果有差异，这本属医学研究上可容许范围，虽然结构文体上有相似度，仍然不构成学术剽窃Plagiarism之定义上事实。因此，论文剽窃相关事件不存在。
洪仲丘事件记者会发言
2013年7月18日，时逢洪仲丘事件发生，而在当日，时任陆军后勤指挥部军医处处长占少]缺的陈建同被请去参与由时任陆军司令李翔宙上将、政战主任曾有福中将、陆军六军团指挥官陈泉官中将等人亲自召开与全程参与的陆军司令部记者会说明洪仲丘案相关事证。